Elsevier

Kidney International

Volume 97, Issue 6, June 2020, Pages 1091-1093
Kidney International

Nephrology Digest
COVID-19
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2

https://doi.org/10.1016/j.kint.2020.04.009Get rights and content
Under a Creative Commons license
open access

Keywords

ACE2
COVID-19
renin-angiotensin system
viral infection

Cited by (0)

Refers to: Monteil V, Kwon H, Prado P, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 [e-pub ahead of print]. Cell. https://doi.org/10.1016/j.cell.2020.04.004. Accessed April 9, 2020.